NCT06514521 2025-12-30
Post Marketing Study on Pluvicto in Korea
Novartis
Recruiting
Clinical Trials
9 trialsNCT06031805 2025-10-28
PROWESs
AstraZeneca
Recruiting
NCT02141438 2025-10-16
REASSURE
Bayer
Completed
NCT05116579 2024-09-05
Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)
Sun Yat-sen University
Recruiting
NCT06529549 2024-07-31
Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment
Sun Yat-sen University
Recruiting
NCT06242509 2024-02-05
AkkPRO
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05301062 2023-09-22
CREDIT
Bayer
Terminated
NCT04000776 2023-08-28
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer
Université de Sherbrooke
Completed
NCT04268628 2022-01-03
EXPLORE
Janssen-Cilag Farmaceutica Ltda.
Completed